Multiple Sclerosis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People of any sex who have been diagnosed with Multiple Sclerosis (MS) according to the 2017 McDonald's criteria and are currently in recovery on disease-modifying therapy (a type of MS medication).
- People with MS who are experiencing gut or liver symptoms — such as difficulty swallowing, vomiting, or reflux — that cannot be explained by a known cause such as hepatitis, a metabolic disorder, drug side effects, or alcohol use.
- Participants must be willing to provide written informed consent, and the study has been approved by the ethics committee at the Faculty of Medicine, Assiut University.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who were already diagnosed with a gut or digestive disorder before their MS diagnosis.
- People who have another condition, or who are taking medications, that could affect their nervous system or gut (confirm with trial site).
- People who are unable or unwilling to attend follow-up visits and regular MRI scans.
- People who are not willing to sign the written informed consent form.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 01013582879
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Detection of Prevalence of git and hepatic manifestation in people with MS and its relations to MS treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.